VivoSeq
Other

Deep Brain Stimulation

0

Pipeline Programs

2

Active Trials

0

Companies Involved

Deep Brain Stimulation is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

86/100

Attrition Rate

8/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

13

clinical trials

Completed6 · 46%
Unknown status4 · 31%
Recruiting2 · 15%
Withdrawn1 · 8%

Trial Activity

13 trials

Anesthesia for Deep Brain Stimulation
Completed··Phase 4·NCT01789385·26 enrolled
Deep Brain Stimulation for Alzheimer's Disease
Unknown status··N/A·NCT03959124·30 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)